Effect of estramustine phosphate (Estracyt®) on transplantable mouse tumours

[1]  G. Murphy,et al.  Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma. , 1977, Urology.

[2]  U. Seal,et al.  Effect of oral estramustine phosphate on pituitary, gonadal, and adrenal function in the green monkey (Cercopithecus aethiops sabaeus). , 1977, Investigative urology.

[3]  S. Loening,et al.  A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. , 1977, The Journal of urology.

[4]  D. S. Coffey,et al.  Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. , 1977, Cancer treatment reports.

[5]  H. Yamanaka,et al.  Effect of estracyt on the rat prostate. , 1977, Investigative urology.

[6]  G. Murphy,et al.  Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate. , 1976, New York state journal of medicine.

[7]  E. Lindstedt,et al.  The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer. , 1976, Investigative urology.

[8]  Høisaeter Pa.  Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts. , 1976 .

[9]  P. Høisaeter.  Studies on the conversion of oestradiol linked to a cytostatic agent (Estracyt) in various rat tissues. , 1976, Acta endocrinologica.

[10]  G. Murphy,et al.  Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate. , 1976, The Journal of urology.

[11]  P. Høisaeter.  THE EFFECT OF OESTRADIOL-3N-BIS-(2-CHLOROETHYL)CARBAMATE-17β-PHOSPHATE (ESTRACYT®) ON THE 5α-REDUCTASE IN THE RAT VENTRAL PROSTATE , 1975 .

[12]  Høisaeter Pa.  Incorporation of 3H-thymidine into rat ventral prostate in organ culture. Influence of hormone-cytostatic complexes. , 1975 .

[13]  N. Bruchovsky,et al.  Androgen receptors: relationship to growth response and to intracellular androgen transport in nine variant lines of the Shionogi mouse mammary carcinoma. , 1975, Biochimica et biophysica acta.

[14]  H. Kasai,et al.  5α-Reduction and Binding of Testosterone in Androgen-Dependent and -Independent Mouse Mammary Tumors12 , 1974 .

[15]  K. Matsumoto,et al.  5Alpha-reduction and binding of testosterone in androgen-dependent and -independent mouse mammary tumors. , 1974, Endocrinology.

[16]  Høisaeter Pa.  Studies on hormone-cytostatic complexes in the cytoplasm of rat prostatic gland. , 1974 .

[17]  G. Murphy,et al.  Studies of Antiprostatic Agents in the Baboon 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  G. Murphy,et al.  Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol. , 1974, Cancer research.

[19]  B. Lindberg.  Treatment of rapidly progressing prostatic carcinoma with estracyt. , 1972, The Journal of urology.

[20]  K. Yamaguchi,et al.  An androgen-dependent mouse mammary tumor. , 1965, Cancer research.

[21]  K. Yamaguchi,et al.  An androgen-dependent tumor derived from a hormone- independent spontaneous tumor of a female mouse , 1964 .

[22]  A. Sandberg,et al.  Studies on phenolic steroids in human subjects. , 1956, Archives of biochemistry and biophysics.

[23]  C. Stock,et al.  Studies in a tumor spectrum. I. Comparison of the action of methylbis(2‐chloroethyl)amine and 3‐bis(2‐chloroethyl)aminomethyl‐4‐methoxymethyl‐5‐hydroxy‐6‐methylpyridine on the growth of a variety of mouse and rat tumors , 1952, Cancer.

[24]  P. Høisaeter.  Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts. , 1976, Investigative urology.

[25]  P. Høisaeter.  Studies on hormone-cytostatic complexes in the cytoplasm of rat prostatic gland. , 1974, Investigative urology.

[26]  B. Högberg,et al.  Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report. , 1971, Scandinavian journal of urology and nephrology.